Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05804032
Title Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Heidelberg Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU | AUT


No variant requirements are available.